Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 5/20 | 0.39 |
| ▸ | KDR | P35968 | 5/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.39 |
| ▸ | KIT | P10721 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19512760 | 0.86 | MET (0.45) | CYP2A6KEAP1NFE2L2NOS3NOS1 | |
| SCHEMBL30876968 | 0.86 | MET (0.45) | CYP2A6KEAP1NFE2L2NOS3NOS1 | |
| SCHEMBL20182695 | 0.78 | KEAP1 (0.39) | CYP2A6KEAP1NFE2L2NOS3NOS1 | |
| SCHEMBL22584046 | 0.78 | NOS3 (0.45) | CYP2A6KEAP1NFE2L2NOS3NOS1 | |
| SCHEMBL12011959 | 0.78 | HTR1D (0.44) | KEAP1NFE2L2ALDH1A1LMNAHPGD | |
| SCHEMBL20807999 | 0.76 | L3MBTL1 (0.40) | ALDH1A1HPGDFLT1KDRPDGFRB | |
| SCHEMBL8554191 | 0.74 | FLT1 (0.37) | FLT1KDRPDGFRBCYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL11418372 | 0.74 | NOS3 (0.45) | CYP2A6NOS3NOS1NOS2ALDH1A1 | |
| SCHEMBL1501358 | 0.74 | ADRA2C (0.52) | ADRA2CALDH1A1LMNAHPGDMAPK1 | |
| SCHEMBL20682499 | 0.73 | NOS3 (0.41) | CYP2A6NOS3NOS1NOS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286968-A1 | ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2023-09-14 | — | — | US | disclosed |
| US-7473307-B2 | Electroless copper plating solution, method of producing the same and electroless copper plating method | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-01-06 | — | — | US | disclosed |
| US-20080223253-A1 | ELECTROLESS COPPER PLATING SOLUTION, METHOD OF PRODUCING THE SAME AND ELECTROLESS COPPER PLATING METHOD | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-09-18 | — | — | US | disclosed |
| US-6989329-B2 | Method of manufacturing a wiring substrate and an electroless copper plating solution for providing interlayer connections | HITACHI, LTD. (JP) | 2006-01-24 | — | — | US | disclosed |
| US-20050042366-A1 | Method of manufacturing a wiring substrate and an electroless copper plating solution for providing interlayer connections | ITABASHI TAKEYUKI (JP) | 2005-02-24 | — | — | US | disclosed |
| US-6831009-B2 | Wiring substrate and an electroless copper plating solution for providing interlayer connections | HITACHI, LTD. (JP) | 2004-12-14 | — | — | US | disclosed |
| CN-1357647-A | Wiring substrate and its making process and chemical copper plating solution therein | HITACHI LTD (JP) | 2002-07-10 | — | — | CN | disclosed |
| US-20020064947-A1 | Wiring substrate and manufacturing method of the same along with electroless copper plating solution used therefor | HITACHI, LTD. (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1196016-A2 | Wiring substrate and manufacturing method of the same along with electroless copper plating solution used therefor | Hitachi, Ltd. (JP) | 2002-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230286968-A1 | ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HAVCR2, CYP4B1, CYP1B1 | ADRA2C 649/4885CYP2A6 32/4885KEAP1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.